RITI® rhumato
a déjà parcouru un long chemin
et sa commercialisation est proche !

Retracer le parcours Être informé(e)
2006
Start of R&D
of the RITI® rheumatoid test
2016
Creation of the company MyXpression
Young innovative company responsible for the project and development of the RITI® rheumatoid test
2022
RITI® rheumatoid obtains
CE marking
and meets European requirements
2023
Start of clinical trial
A clinical trial in progress
within 10 French investigating centers
2025
RITI® rheumatoid
soon on sale
Decorative element
Decorative element
Decorative element
Decorative element
Soyez informé(e) de la disponibilité du test RITI® rhumato
en remplissant le formulaire ci-dessous* :

*champs obligatoires

J'accepte la politique de confidentialité du présent site Lire notre politique de confidentialité.

F.A.Q

When the RITI® rheumatoid test is marketed, a doctor/patient interface will be made available to you so that you can manage your patients' prescriptions and test results.

To have the RITI® rheumatoid test, you will need to make a request to your rheumatologist who wishes to prescribe biotherapy. You can present the RITI® rheumatoid solution to them by downloading the document “talk to my rheumatologist”

It is not recommended to obtain the RITI® rhumato test without first discussing it with your referring rheumatologist; Indeed, only he is authorized to prescribe a biotherapy and therefore to choose whether or not to use the results of your test to make his choice.